Tratamiento del melanoma avanzado con tafinlar (DABRAFENIB) + MEKINIST (TRAMETINIB) - page 17

Long et al 2016 Lancet Oncol

Mediana 11,1 meses SLP

48% 1 año

30% 2 años

Mediana 25,6 meses SG

75% 1 año

53% 2 años

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,7,8,9,10,11,12,13,14,15,16 18,19,20,21,22,23,24,25,26,27,...29